Supply of Paracetamol Osteo-Tab 665 mg modified release tablet blister pack and bottle by AFT Pharmaceuticals

Administered by Department of Health, Disability and Ageing

Legislation au C2012G00256 In force Gazette

Legislation content

SECTion 14 AND 14A NOTICE

 

I, MAYADA KAYALI, delegate of the Secretary to the Department of Health and Ageing for the purposes of sections 14, 14A and 15 of the Therapeutic Goods Act 1989 (‘the Act’) hereby give my consent, pursuant to sections 14 and 14A of the Act, for AFT Pharmaceuticals, 296 Burns Bay Road, Lane Cove, NSW 1595 to supply Paracetamol Osteo-Tab 665 mg modified release tablet blister pack (AUST R 202406) and Paracetamol Osteo-Tab 665 mg modified release tablet bottle (AUST R 202407) that do not comply with the requirements of the US Pharmacopoeia monograph for Acetaminophen Extended Release Tablets with regards to the test and limits for dissolution.

 

Pursuant to section 15(1) of the Act, my consent is subject to the following conditions:

 

  1. The product complies with all other aspects of the standard.

 

 

 

(Signed by)

 

Mayada Kayali

Delegate of the Secretary

Office of Medicines Authorisation

 

  2 November 2012

 

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.